Search research articles
Contact Us
Filters
Showing results (21-30 of 99) with videos related to
Page
of 10
Sort By:
International Journal of Cancer
|
August 15, 1981
In vivo anti-tumor effects of local adoptive transfer of mouse and human cultured lymphoid cells
E Gorelik, E Kedar, B Sredni, et al.
Journal of Clinical Immunology
|
March 1, 1990
The effect of a single whole-blood transfusion on cytokine secretion
Y Kalechman, U Gafter, D Sobelman, et al.
Immunopharmacology
|
March 1, 1995
Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties
Y Kalechman, A Shani, M Albeck, et al.
International Journal of Immunopharmacology
|
May 1, 1992
The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent
B Sredni, M Albeck, G Kazimirsky, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1984
Chemical reduction of oxidized human lymphocytes inhibits interleukin 2 production but not induction of interleukin 2 responsiveness
E Roffman, B Sredni, A Smolinsky, et al.
Research Communications in Molecular Pathology and Pharmacology
|
January 1, 1995
The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesions
R H Xu, Y Kalechman, M Albeck, et al.
Experimental Hematology
|
December 1, 1992
The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment
Y Kalechman, I Sotnik-Barkai, M Albeck, et al.
Immunology
|
March 1, 1977
Colony growth in vitro of mitogen-stimulated mouse B lymphocytes
L A Rozenszajn, H Michlin, Y Kalechman, et al.
Cancer Research
|
April 15, 1993
Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101)
Y Kalechman, I Sotnik-Barkai, M Albeck, et al.
Experimental Hematology
|
December 1, 1995
Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice
Y Kalechman, G Rushkin, J Nerubay, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 99) with videos related to
Sort By:
Page
of 10
International Journal of Cancer
|
August 15, 1981
In vivo anti-tumor effects of local adoptive transfer of mouse and human cultured lymphoid cells
E Gorelik, E Kedar, B Sredni, et al.
Journal of Clinical Immunology
|
March 1, 1990
The effect of a single whole-blood transfusion on cytokine secretion
Y Kalechman, U Gafter, D Sobelman, et al.
Immunopharmacology
|
March 1, 1995
Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties
Y Kalechman, A Shani, M Albeck, et al.
International Journal of Immunopharmacology
|
May 1, 1992
The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent
B Sredni, M Albeck, G Kazimirsky, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1984
Chemical reduction of oxidized human lymphocytes inhibits interleukin 2 production but not induction of interleukin 2 responsiveness
E Roffman, B Sredni, A Smolinsky, et al.
Research Communications in Molecular Pathology and Pharmacology
|
January 1, 1995
The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesions
R H Xu, Y Kalechman, M Albeck, et al.
Experimental Hematology
|
December 1, 1992
The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment
Y Kalechman, I Sotnik-Barkai, M Albeck, et al.
Immunology
|
March 1, 1977
Colony growth in vitro of mitogen-stimulated mouse B lymphocytes
L A Rozenszajn, H Michlin, Y Kalechman, et al.
Cancer Research
|
April 15, 1993
Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101)
Y Kalechman, I Sotnik-Barkai, M Albeck, et al.
Experimental Hematology
|
December 1, 1995
Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice
Y Kalechman, G Rushkin, J Nerubay, et al.
Page
of 10